{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:16:59Z","timestamp":1792181819386,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.talanta.2020.120747","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T20:15:46Z","timestamp":1579032946000},"page":"120747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["SWATH data independent acquisition mass spectrometry for screening of xenobiotics in biological fluids: Opportunities and challenges for data processing"],"prefix":"10.1016","volume":"211","author":[{"given":"Frank","family":"Klont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Grivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Hopfgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2020.120747_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00216-007-1248-5","article-title":"Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology","volume":"388","author":"Maurer","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trac.2014.11.009","article-title":"Targeted and non-targeted liquid chromatography-mass spectrometric workflows for identification of transformation products of emerging pollutants in the aquatic environment","volume":"66","author":"Bletsou","year":"2015","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.120747_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.aca.2016.07.023","article-title":"Determination of pesticides and veterinary drug residues in food by liquid chromatography-mass spectrometry: a review","volume":"936","author":"Masi\u00e1","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.120747_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC-MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.120747_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.trac.2014.04.005","article-title":"Liquid chromatography-mass spectrometry for the determination of chemical contaminants in food","volume":"59","author":"Hird","year":"2014","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.120747_bib6","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1007\/s00216-015-8681-7","article-title":"Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis","volume":"407","author":"Schymanski","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpba.2017.12.025","article-title":"High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis","volume":"151","author":"Abushareeda","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.120747_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.forsciint.2018.03.039","article-title":"Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry","volume":"287","author":"Grapp","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.talanta.2020.120747_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.trac.2016.01.028","article-title":"Knowing the unknown \u2013 state of the art of LCMS in toxicology","volume":"84","author":"Rentsch","year":"2016","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.120747_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clinbiochem.2010.08.018","article-title":"HPLC-high resolution mass spectrometry in clinical laboratory?","volume":"44","author":"Jiwan","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2020.120747_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00216-012-5726-z","article-title":"Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control","volume":"403","author":"Ojanper\u00e4","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatographyhigh-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.talanta.2020.120747_bib13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00204-016-1764-1","article-title":"High-resolution mass spectrometry in toxicology: current status and future perspectives","volume":"90","author":"Maurer","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.talanta.2020.120747_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.envint.2016.11.026","article-title":"Trends in the application of high-resolution mass spectrometry for human biomonitoring: an analytical primer to studying the environmental chemical space of the human exposome","volume":"100","author":"Andra","year":"2017","journal-title":"Environ. Int."},{"key":"10.1016\/j.talanta.2020.120747_bib15","first-page":"307","article-title":"Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications, Proteomics - Clin","volume":"9","author":"Sajic","year":"2015","journal-title":"Appl"},{"key":"10.1016\/j.talanta.2020.120747_bib16","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.O111.016717","article-title":"Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis","volume":"11","author":"Gillet","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.talanta.2020.120747_bib17","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00216-011-5641-8","article-title":"High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices","volume":"402","author":"Hopfgartner","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib18","article-title":"SWATH data independent acquisition mass spectrometry for metabolomics","author":"Bonner","year":"2018","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.120747_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pmic.201400323","article-title":"Processing strategies and software solutions for data-independent acquisition in mass spectrometry","volume":"15","author":"Bilbao","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.talanta.2020.120747_bib20","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00216-018-0860-x","article-title":"Metabolomic spectral libraries for data-independent SWATH liquid chromatography mass spectrometry acquisition","volume":"410","author":"Bruderer","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib21","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.1021\/ac503144p","article-title":"Liquid chromatography, in combination with a quadrupole time-of-flight instrument (LC QTOF), with sequential window acquisition of all theoretical fragment-ion spectra (SWATH) acquisition: systematic studies on its use for screenings in clinical and foren","volume":"86","author":"Roemmelt","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib22","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1021\/acs.analchem.5b02031","article-title":"Liquid chromatography, in combination with a quadrupole time-of-flight instrument, with sequential window acquisition of all theoretical fragment-ion spectra acquisition: validated quantification of 39 antidepressants in whole blood as part of a simultane","volume":"87","author":"Roemmelt","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00216-014-8262-1","article-title":"Applying \u201csequential windowed acquisition of all theoretical fragment ion mass spectra\u201d (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry","volume":"407","author":"Arnhard","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib24","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1007\/s00216-017-0594-1","article-title":"Assessment of simpler calibration models in the development and validation of a fast postmortem multi-analyte LC-QTOF quantitation method in whole blood with simultaneous screening capabilities using SWATH acquisition","volume":"409","author":"Elmiger","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1373\/clinchem.2018.300756","article-title":"Optimization and comparison of information-dependent acquisition (IDA) to sequential window acquisition of all theoretical fragment ion spectra (SWATH) for high-resolution mass spectrometry in clinical toxicology","volume":"65","author":"Whitman","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00216-011-4708-x","article-title":"On-line SPE LC-MS\/MS for the quantification of \u03949- tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry","volume":"400","author":"K\u00f6nig","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09595230412331289482","article-title":"A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions","volume":"23","author":"Kelly","year":"2004","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.talanta.2020.120747_bib29","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1002\/wfs2.1326","article-title":"Driving under the influence of drugs","volume":"1","author":"Marillier","year":"2019","journal-title":"WIREs Forensic Sci"},{"key":"10.1016\/j.talanta.2020.120747_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.forsciint.2016.02.033","article-title":"The cutting of cocaine and heroin: a critical review","volume":"262","author":"Bros\u00e9us","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.talanta.2020.120747_bib31","first-page":"16","article-title":"Adulterants and diluents in heroin, amphetamine, and cocaine found on the illicit drug market in aarhus, Denmark, open forensic sci","volume":"2","author":"Andreasen","year":"2009","journal-title":"J"},{"key":"10.1016\/j.talanta.2020.120747_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4155\/bio-2016-0281","article-title":"Rapid quantification of free and glucuronidated THCCOOH in urine using coated well plates and LC-MS\/MS analysis","volume":"9","author":"H\u00e4dener","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2020.120747_bib33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/138920111795909078","article-title":"How unbiased is non-targeted metabolomics and is targeted pathway screening the solution?","volume":"12","author":"Christians","year":"2011","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.talanta.2020.120747_bib34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/acs.analchem.7b03929","article-title":"Annotation: a computational solution for streamlining metabolomics analysis","volume":"90","author":"Domingo-Almenara","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib35","first-page":"92","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Curr. Metabolomics."},{"key":"10.1016\/j.talanta.2020.120747_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.aca.2016.02.001","article-title":"Chemometric methods in data processing of mass spectrometry-based metabolomics: a review","volume":"914","author":"Yi","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.120747_bib37","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/ac800110w","article-title":"Dimensionality reduction and visualization in principal component analysis","volume":"80","author":"Ivosev","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac051495j","article-title":"Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation","volume":"78","author":"Bijlsma","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1373\/clinchem.2008.114405","article-title":"Intra-and intersubject whole blood\/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing","volume":"55","author":"Schwilke","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-198223010-00004","article-title":"Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics","volume":"23","author":"Prescott","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.talanta.2020.120747_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dta.2137","article-title":"IRMS to study a common cocaine cutting agent: phenacetin","volume":"9","author":"Ladroue","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.talanta.2020.120747_bib42","series-title":"Regul. Bioanal. Fundam. Pract.","first-page":"103","article-title":"Fundamentals of LC-MS\/MS for regulated bioanalysis","author":"Schultz","year":"2017"},{"key":"10.1016\/j.talanta.2020.120747_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.120747_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1097-0231(19970115)11:1<17::AID-RCM812>3.0.CO;2-N","article-title":"The simultaneous determination of mixtures of drug candidates by liquid chromatography\/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure","volume":"11","author":"Olah","year":"1997","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.120747_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/ac9911701","article-title":"Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC\/MS","volume":"72","author":"Zhang","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.120747_bib46","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","article-title":"Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics","volume":"11","author":"Peterson","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.talanta.2020.120747_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/dta.2336","article-title":"Annual banned-substance review: analytical approaches in human sports drug testing","volume":"10","author":"Thevis","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.talanta.2020.120747_bib48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1210\/js.2018-00135","article-title":"GC\/MS in recent years has defined the normal and clinically disordered steroidome: will it soon Be surpassed by LC\/tandem MS in this role?","volume":"2","author":"Shackleton","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.talanta.2020.120747_bib49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jsbmb.2010.04.010","article-title":"Gas chromatography\/mass spectrometry (GC\/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC\/MS\/MS)","volume":"121","author":"Krone","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020300382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020300382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:35:44Z","timestamp":1758544544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914020300382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":48,"alternative-id":["S0039914020300382"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2020.120747","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SWATH data independent acquisition mass spectrometry for screening of xenobiotics in biological fluids: Opportunities and challenges for data processing","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2020.120747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120747"}}